Volgen
Ymkje Stienstra
Ymkje Stienstra
tenure-track professor UMCG, Department of internal medicine/infectious diseases, Groningen, The
Geverifieerd e-mailadres voor umcg.nl - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non–cystic fibrosis bronchiectasis: the BAT randomized controlled trial
J Altenburg, CS de Graaff, Y Stienstra, JH Sloos, EHJ van Haren, ...
Jama 309 (12), 1251-1259, 2013
5892013
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial
WA Nienhuis, Y Stienstra, WA Thompson, PC Awuah, KM Abass, W Tuah, ...
The Lancet 375 (9715), 664-672, 2010
3422010
Mycobacterium ulcerans disease
TS van der Werf, Y Stienstra, RC Johnson, R Phillips, O Adjei, B Fleischer, ...
Bulletin of the World Health Organization 83, 785-791, 2005
2242005
Quality of interhospital transport of critically ill patients: a prospective audit
JJM Ligtenberg, LG Arnold, Y Stienstra, TS van der Werf, JHJM Meertens, ...
Critical Care 9, 1-6, 2005
2182005
Beliefs and attitudes toward Buruli ulcer in Ghana.
Y Stienstra, WTA van der Graaf, K Asamoa, TS van der Werf
The American journal of tropical medicine and hygiene 67 (2), 207-213, 2002
2172002
Risk Factors for Buruli Ulcer Disease (Mycobacterium ulcerans Infection): Results from a Case-Control Study in Ghana
PL Raghunathan, EAS Whitney, K Asamoa, Y Stienstra, TH Taylor Jr, ...
Clinical Infectious Diseases 40 (10), 1445-1453, 2005
2052005
Histopathologic features of Mycobacterium ulcerans infection
J Guarner, J Bartlett, EAS Whitney, PL Raghunathan, Y Stienstra, ...
Emerging infectious diseases 9 (6), 651, 2003
1912003
Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection
WA Nienhuis, Y Stienstra, KM Abass, W Tuah, WA Thompson, PC Awuah, ...
Clinical infectious diseases 54 (4), 519-526, 2012
1272012
Mycolactones and Mycobacterium ulcerans disease
TS van der Werf, T Stinear, Y Stienstra, WTA van der Graaf, PL Small
The Lancet 362 (9389), 1062-1064, 2003
1172003
Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors
Y Stienstra, WTA Van Der Graaf, GJ Te Meerman, TH The, LF De Leij, ...
Tropical Medicine & International Health 6 (7), 554-562, 2001
1102001
Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors
Y Stienstra, WTA Van Der Graaf, GJ Te Meerman, TH The, LF De Leij, ...
Tropical Medicine & International Health 6 (7), 554-562, 2001
1102001
Variability of antibiotic susceptibility and toxin production of Staphylococcus aureus strains isolated from skin, soft tissue, and bone related infections
H Sina, TA Ahoyo, W Moussaoui, D Keller, HS Bankolé, Y Barogui, ...
BMC microbiology 13, 1-9, 2013
992013
Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors
ME Hettema, D Zhang, K de Leeuw, Y Stienstra, AJ Smit, CGM Kallenberg, ...
Arthritis research & therapy 10, 1-8, 2008
902008
Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism
Y Stienstra, TS Van Der Werf, E Oosterom, IM Nolte, WTA Van der Graaf, ...
Genes & Immunity 7 (3), 185-189, 2006
892006
Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients
Y Stienstra, MHG van Roest, MJ van Wezel, IC Wiersma, IC Hospers, ...
Tropical Medicine & International Health 10 (12), 1251-1257, 2005
872005
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
RO Phillips, J Robert, KM Abass, W Thompson, FS Sarfo, T Wilson, ...
The Lancet 395 (10232), 1259-1267, 2020
862020
Functional limitations after surgical or antibiotic treatment for Buruli ulcer in Benin
Y Barogui, RC Johnson, TS van der Werf, G Sopoh, A Dossou, ...
American Journal of Tropical Medicine and Hygiene 81 (1), 82, 2009
842009
Long term streptomycin toxicity in the treatment of Buruli ulcer: follow-up of participants in the BURULICO drug trial
S Klis, Y Stienstra, RO Phillips, KM Abass, W Tuah, TS van der Werf
PLoS Neglected Tropical Diseases 8 (3), e2739, 2014
762014
Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members
AA Mulder, RP Boerma, Y Barogui, C Zinsou, RC Johnson, J Gbovi, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 102 (9 …, 2008
762008
Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana
BD Westenbrink, Y Stienstra, MG Huitema, WA Thompson, EO Klutse, ...
Clinical and Vaccine Immunology 12 (1), 125-129, 2005
732005
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20